# 2025-19054: DEA Revokes California MD's Drug Handling License

2025-19054, David Payne, M.D.; Decision and Order, is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2025-09-30, effective 2025-10-30; PRIA reads it as touching household money (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2025-19054
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-19054
- Title: David Payne, M.D.; Decision and Order
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 90 FR 46925
- Published: 2025-09-30
- Effective: 2025-10-30
- Comments close: not stated
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

DEA Revokes California MD's Drug Handling License

## Summary

Dr. David Payne from California lost his DEA license to handle controlled substances because he’s no longer allowed to prescribe or participate in federal health programs. He didn’t ask for a hearing, so the DEA made the decision final. This means he can’t legally prescribe or manage controlled drugs starting now, impacting his medical practice and federal program involvement.

## Effects PRIA read

- DEA Registration Revoked for David Payne: cost, high. The Drug Enforcement Administration revoked David Payne, M.D.'s DEA Certificate of Registration No. BP3113963 and denied any pending applications to renew, modify, or obtain additional registration in California. The Order takes effect October 30, 2025, and follows findings that his California medi…
- 14-Year Federal Health Program Exclusion: cost, high. The record shows David Payne, M.D. was mandatorily excluded from participation in Medicare, Medicaid, and all Federal health care programs effective May 20, 2024, for a period of fourteen years. That exclusion is an independent basis the DEA relied on to revoke his registration.

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22843](https://policyrisk.com/federal-register/2026-22843): Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ep…, 2026-11-10
- [2026-22842](https://policyrisk.com/federal-register/2026-22842): Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sal…, 2026-11-10

## Sources
- [2025-19054 on federalregister.gov](https://www.federalregister.gov/documents/2025/09/30/2025-19054/david-payne-md-decision-and-order)
- [2025-19054 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-09-30/pdf/2025-19054.pdf)

## Related
- [Previous: 2025-19053, Self-Regulatory Organizations; Financial Industry Regulatory Authority, Inc.; N…](https://policyrisk.com/federal-register/2025-19053)
- [Next: 2025-19056, Self-Regulatory Organizations; Fixed Income Clearing Corporation; Notice of Fil…](https://policyrisk.com/federal-register/2025-19056)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-19054 (as of 2026-06-08).
